Complex patterns of concomitant medication use: A study among Norwegian women using paracetamol during pregnancy
- PMID: 29284043
- PMCID: PMC5746239
- DOI: 10.1371/journal.pone.0190101
Complex patterns of concomitant medication use: A study among Norwegian women using paracetamol during pregnancy
Abstract
Background: Studies on medication safety in pregnancy often rely on an oversimplification of medication use into exposed or non-exposed, without considering intensity and timing of use in pregnancy, or concomitant medication use. This study uses paracetamol in pregnancy as the motivating example to introduce a method of clustering medication exposures longitudinally throughout pregnancy. The aim of this study was to use hierarchical cluster analysis (HCA) to better identify clusters of medication exposure throughout pregnancy.
Methods: Data from the Norwegian Mother and Child Cohort Study was used to identify subclasses of women using paracetamol during pregnancy. HCA with customized distance measure was used to identify clusters of medication exposures in pregnancy among children at 18 months.
Results: The pregnancies in the study (N = 9 778) were grouped in 5 different clusters depending on their medication exposure profile throughout pregnancy.
Conclusion: Using HCA, we identified and described profiles of women exposed to different medications in combination with paracetamol during pregnancy. Identifying these clusters allows researchers to define exposure in ways that better reflects real-world medication usage patterns. This method could be extended to other medications and used as pre-analysis for identifying risks associated with different profiles of exposure.
Conflict of interest statement
Figures
References
-
- Grzeskowiak LE, Gilbert AL, Morrison JL. Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy. Eur J Clin Pharmacol. 2012;68(5):459–67. doi: 10.1007/s00228-011-1154-9 PubMed PMID: WOS:000303452800003. - DOI - PubMed
-
- Wood ME, Lapane K, Frazier JA, Ystrom E, Mick EO, Nordeng H. Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study. Paediatr Perinat Ep. 2016;30(2):190–200. doi: 10.1111/ppe.12253 PubMed PMID: WOS:000370249000011. - DOI - PMC - PubMed
-
- Hurault-Delarue C, Chouquet C, Savy N, Lacroix I, Beau AB, Montastruc JL, et al. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women? Pharmacoepidem Dr S. 2016;25(7):770–7. doi: 10.1002/pds.4000 PubMed PMID: WOS:000379843100004. - DOI - PubMed
-
- WHOCC. Definition and general considerations. 2016. [April 26, 2017]. Available from: https://www.whocc.no/ddd/definition_and_general_considera/.
-
- Hurault-Delarue C, Chouquet C, Savy N, Lacroix I, Beau AB, Montastruc JL, et al. Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics. Pharmacoepidemiol Drug Saf. 2017. doi: 10.1002/pds.4199 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
